Health Care [ 7/12 ] | Biotechnology [ 56/74 ]
NASDAQ | Common Stock
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases.
The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013.
PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 26 | -0.34 Increased by 0.00% | -0.38 Increased by +10.53% |
| Mar 5, 26 | -0.34 Increased by +24.44% | -0.41 Increased by +18.07% |
| Nov 12, 25 | -0.40 Decreased by -8.11% | -0.40 |
| Aug 7, 25 | -0.41 Decreased by -1.95 K% | -0.38 Decreased by -7.89% |
| May 9, 25 | -0.34 Decreased by -13.33% | -0.37 Increased by +8.11% |
| Feb 26, 25 | -0.45 Decreased by -45.16% | -0.38 Decreased by -18.42% |
| Nov 7, 24 | -0.37 Decreased by -8.82% | -0.36 Decreased by -2.78% |
| Aug 8, 24 | -0.02 Increased by +94.74% | -0.34 Increased by +94.12% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -18.04 M Decreased by -3.45% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -18.04 M Increased by +21.58% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -21.06 M Decreased by -9.53% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -21.21 M Decreased by -1.65 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -17.44 M Decreased by -14.18% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -23.00 M Decreased by -45.98% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -19.23 M Decreased by -15.54% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.21 M Increased by +93.04% | Decreased by N/A% Decreased by N/A% |